标题
Nurr1:RXRα heterodimer activation as monotherapy for Parkinson’s disease
作者
关键词
-
出版物
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 114, Issue 15, Pages 3999-4004
出版商
Proceedings of the National Academy of Sciences
发表日期
2017-03-28
DOI
10.1073/pnas.1616874114
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Nurr1 and Retinoid X Receptor Ligands Stimulate Ret Signaling in Dopamine Neurons and Can Alleviate -Synuclein Disrupted Gene Expression
- (2015) N. Volakakis et al. JOURNAL OF NEUROSCIENCE
- Contra-directional Coupling of Nur77 and Nurr1 in Neurodegeneration: A Novel Mechanism for Memantine-Induced Anti-inflammation and Anti-mitochondrial Impairment
- (2015) Xiaobo Wei et al. MOLECULAR NEUROBIOLOGY
- New treatments for levodopa-induced motor complications
- (2015) Olivier Rascol et al. MOVEMENT DISORDERS
- Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial
- (2014) Stéphane Palfi et al. LANCET
- The ongoing pursuit of neuroprotective therapies in Parkinson disease
- (2014) Dilan Athauda et al. Nature Reviews Neurology
- Low Dose Bexarotene Treatment Rescues Dopamine Neurons and Restores Behavioral Function in Models of Parkinson’s Disease
- (2013) Krista McFarland et al. ACS Chemical Neuroscience
- Genetic Correction of a LRRK2 Mutation in Human iPSCs Links Parkinsonian Neurodegeneration to ERK-Dependent Changes in Gene Expression
- (2013) Peter Reinhardt et al. Cell Stem Cell
- Therapy for Parkinson’s Disease: What is in the Pipeline?
- (2013) Fabrizio Stocchi Neurotherapeutics
- Derivation and Expansion Using Only Small Molecules of Human Neural Progenitors for Neurodegenerative Disease Modeling
- (2013) Peter Reinhardt et al. PLoS One
- Transcription factor Nurr1 maintains fiber integrity and nuclear-encoded mitochondrial gene expression in dopamine neurons
- (2013) B. Kadkhodaei et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pollination Decline in Context--Response
- (2013) J. M. Tylianakis SCIENCE
- Advances in drug design with RXR modulators
- (2012) Belén Vaz et al. Expert Opinion on Drug Discovery
- When does Parkinson's disease begin? From prodromal disease to motor signs
- (2012) W.G. Meissner REVUE NEUROLOGIQUE
- ApoE-Directed Therapeutics Rapidly Clear -Amyloid and Reverse Deficits in AD Mouse Models
- (2012) P. E. Cramer et al. SCIENCE
- Modulation of RXR function through ligand design
- (2011) Efrén Pérez et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Monoamine Oxidase B Inhibitors for the Treatment of Parkinsonʼs Disease
- (2011) Anthony H.V. Schapira CNS DRUGS
- Priorities in Parkinson's disease research
- (2011) Wassilios G. Meissner et al. NATURE REVIEWS DRUG DISCOVERY
- Age-related changes in dopamine signaling in Nurr1 deficient mice as a model of Parkinson's disease
- (2011) Lifen Zhang et al. NEUROBIOLOGY OF AGING
- Fcγ receptors are required for NF-κB signaling, microglial activation and dopaminergic neurodegeneration in an AAV-synuclein mouse model of Parkinson's disease
- (2010) Shuwen Cao et al. Molecular Neurodegeneration
- The Parkinson Disease Protein Leucine-Rich Repeat Kinase 2 Transduces Death Signals via Fas-Associated Protein with Death Domain and Caspase-8 in a Cellular Model of Neurodegeneration
- (2009) C. C.-Y. Ho et al. JOURNAL OF NEUROSCIENCE
- Nurr1 Is Required for Maintenance of Maturing and Adult Midbrain Dopamine Neurons
- (2009) B. Kadkhodaei et al. JOURNAL OF NEUROSCIENCE
- Characterisation of a novel NR4A2 mutation in Parkinson's disease brain
- (2009) P.M.A. Sleiman et al. NEUROSCIENCE LETTERS
- Dopamine Gene Therapy for Parkinson's Disease in a Nonhuman Primate Without Associated Dyskinesia
- (2009) B. Jarraya et al. Science Translational Medicine
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started